The management of acute venous thromboembolism in clinical practice – study rationale and protocol of the European PREFER in VTE Registry
Authors (first, second and last of 11)
Volume 13, issue 1, December 2015
41 articles in this issue
-
-
Original approach for thrombolytic therapy in patients with Ilio-femoral deep vein thrombosis : 2 years follow-up
Authors (first, second and last of 4)
-
Global Thrombosis Test – a possible monitoring system for the effects and safety of dabigatran
Authors (first, second and last of 9)
-
-
Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery
Authors (first, second and last of 7)
-
Oral dabigatran etexilate versus enoxaparin for venous thromboembolism prevention after total hip arthroplasty: pooled analysis of two phase 3 randomized trials
Authors (first, second and last of 9)
-
Genetic risk factors in patients with deep venous thrombosis, a retrospective case control study on Iranian population
Authors (first, second and last of 6)
-
-
-
Low dose compared to variable dose Warfarin and to Fondaparinux as prophylaxis for thromboembolism after elective hip or knee replacement surgery; a randomized, prospective study
Authors (first, second and last of 12)
-
Markers of thrombin generation are associated with myocardial necrosis and left ventricular impairment in patients with ST-elevation myocardial infarction
Authors (first, second and last of 8)
-
Unsuccessful percutaneous mechanical thrombectomy in fibrin-rich high-risk pulmonary thromboembolism
Authors (first, second and last of 4)
-
-
-
Efficacy and safety of edoxaban versus enoxaparin for the prevention of venous thromboembolism following total hip arthroplasty: STARS J-V
Authors (first, second and last of 8)
-
-
Stent thrombosis caused by metal allergy complicated by protein S deficiency and heparin-induced thrombocytopenia: a case report and review of the literature
Authors (first, second and last of 13)
-
Inhibition of thrombin generation in human plasma by phospholipid transfer protein
Authors (first, second and last of 8)
-
The role of soluble fibrin during anticoagulant therapy: a case report
Authors (first, second and last of 4)
-
Implementation of non-vitamin K antagonist oral anticoagulants in daily practice: the need for comprehensive education for professionals and patients
Authors (first, second and last of 9)
-
Retrospective cohort analysis comparing the incidence of deep vein thromboses between peripherally-inserted and long-term skin tunneled venous catheters in hemato-oncology patients
Authors (first, second and last of 9)
-
Cost-effectiveness analysis of treatment of venous thromboembolism with rivaroxaban compared with combined low molecular weight heparin/vitamin K antagonist
Authors (first, second and last of 6)
-
-
Analysis of the accuracy of the Wells scale in assessing the probability of lower limb deep vein thrombosis in primary care patients practice
Authors (first, second and last of 6)
-
-
-
Thrombosis in vasculitis: from pathogenesis to treatment
Authors (first, second and last of 13)
This is part of 1 collection: -
Thrombosis in inflammatory bowel diseases: what’s the link?
Authors (first, second and last of 5)
This is part of 1 collection:
-
Remarkable regression of massive deep vein thrombosis in response to intensive oral rivaroxaban treatment
Authors (first, second and last of 6)
-
“Role of the adipocyte hormone leptin in cardiovascular diseases – a study from Chennai based Population”
Authors (first, second and last of 5)
-
-
-
-
Assays of different aspects of haemostasis – what do they measure?
Authors
This is part of 1 collection:
-
-
A randomized, open-label trial of edoxaban in Japanese patients with severe renal impairment undergoing lower-limb orthopedic surgery
Authors (first, second and last of 8)
-
-
-
Impact of a high-fat meal on assessment of clopidogrel-induced platelet inhibition in healthy subjects
Authors (first, second and last of 4)
-
Oral rivaroxaban for Japanese patients with symptomatic venous thromboembolism – the J-EINSTEIN DVT and PE program
Authors (first, second and last of 12)
-
